Systemic sclerosis (scleroderma) trials in Finland
2 of 3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Helsinki, Oulu, Turku
- Age
- 18 years and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - Phase 2/3Taking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Turku
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01